 |
|

Research areas of the laboratory
Cardiac arrhythmias remain the major cause of human mortality in the developed
world. Various factors contribute to an abnormal wavefront generation and/or conduction, which may result in dangerous cardiac arrhythmias. We investigate
the mechanisms of wavefront initiation in the sino-atrial node
or by an artificial electronic pacemaker. We also investigate wavefront propagation is cardiac structures with heterogeneous ion channel and gap junction expression, such as atrio-ventricular and sino-atrial nodes. Using fluorescent imaging we
study propagation of electrical impulses in the heart during normal and abnormal cardiac rhythm(s). Specifically, we are interested in extending our understanding of (1) impulse generation (excitation) by
a groups of cells and by local electrical stimulus, (2) impulse termination and break-excitation by strong electrical defibrillating shock, (3) impulse propagation in the structures with strong degree of heterogeneity of ion channel and gap junction expression.
Specific Projects
1. Structure/function of the pacemaking and
conduction system of the heart. The pacemaking and
conduction system (PCS) of the heart is a profoundly complex
structure, which orchestrates orderly contractions of cardiac
chambers by generating and transmitting action potentials at
an appropriate rate, conduction velocity, and delay between
the chambers. As evident from neurofilament 160 staining in
the developing and adult rabbit heart, PCS is anatomically and
functionally a continuous structure. There are various types
of cells within PCS, which differ morphologically. However,
they all have pacemaking properties, unlike cells of the
working atrial and ventricular myocardium which lack them. In
addition to morphological heterogeneity, PCS possesses
striking heterogeneity of functional properties. For example,
there is a nearly 100-fold difference in the conduction
velocity between the anatomically adjacent compact
atrioventricular (AV) node (~2-3 cm/sec) and the His-Purkinje
system (up to 2.5 m/sec). Such a difference is required for
the proper delay of excitation between the atria and
ventricles, on the one hand, and synchronized excitation of
ventricles, on the other hand. We hypothesize that this
functional heterogeneity has both a structural and molecular
basis: heterogeneity of expression of genes encoding gap
junction and ion channels, and receptors of the PCS provides
the substrate for normal and abnormal pacemaking and
conduction and for arrhythmias. We also hypothesize that
quantification of the PCS 3D structure is required to more
completely understand its function. We plan to implement such
quantification, using state-of-the art optical mapping with
voltage-sensitive dye, optical coherence tomography (OCT), and
immunohistochemical mapping of several fundamental proteins,
which define intercellular coupling and cell types. The long
term goal of this project is to develop a structure/function
framework of the cardiac PCS in 3D. Numerous studies examined
contribution of various isoforms of connexins, ion channels,
and receptors to cellular physiology in the pacemaking and
conduction system of the heart. We aim to apply a systems
physiology approach which will lay down foundation for future
integration of molecular and cellular information into a
comprehensive mathematical model of the heart. Our data will
allow us to examine factors responsible for stability of
normal pacemaking and conduction, for abnormal impulse
generation and failed conduction, and for arrhythmogenesis
mediated by the autonomic nervous system and stretch. This new
knowledge will be helpful in future development of novel
genetic and device therapies of PCS abnormalities. We will
also explore the potential of novel OCT imaging technology for
diagnosis and research of PCS abnormalities.
2. Low-voltage defibrillation. According to
the American Heart Association, an “overwhelming number of
sudden cardiac deaths (SCD) from coronary disease (estimated
at about 340,000 per year) is thought to be from ventricular
fibrillation” (VF). Sudden cardiac death usually starts as
ventricular tachycardia (VT) and then degenerates into VF.
Defibrillation by high-intensity electric shock is the only
reliable treatment of VT/VF, which however often results in
myocardial dysfunction and damage. We propose to develop a
novel approach for defibrillation therapy, which may result in
a significant reduction in the energy delivered to the heart.
The current defibrillation approach requires termination of
all propagating waves of excitation in the entire fibrillating
heart. It is commonly assumed that in order to achieve this
goal, one has to deliver an electric field of at least 5.4
V/cm to all or critical amount of myocardium in the heart. We
propose to target only the leading centers that sustain
arrhythmia, rather than the whole organ. The majority of
patients receiving ICD therapy have a history of coronary
disease; their hearts develop anatomical heterogeneities,
which could provide a substrate for reentrant
tachyarrhythmias. Based on our observations we hypothesize
that: (a) The leading center of reentrant tachyarrhythmia
tends to anchor at anatomical heterogeneities, such as
infarction border zones, scars, areas of fibrosis; (b)
Attachment to nonconductive anatomical heterogeneities
stabilizes the leading center and thus reduces the efficacy of
the current low-energy therapy, anti-tachycardia pacing (ATP);
(c) An externally applied electric shock induces maximum
tissue polarization, known as virtual electrode polarization,
at anatomical heterogeneities including the same anatomical
substrate which anchors the leading center of arrhythmia; (d)
A low-energy properly timed (applied during a termination
window) electric shock can destabilize the leading center of
arrhythmia via virtual electrode polarization and unpin it
from the substrate; (e) Following unpinning, arrhythmia can be
terminated by properly timed anti-repining pacing (ARP), which
will terminate VT and prevent its degeneration into VF.
3. The mechanisms of electroporation and its role in
defibrillation. Defibrillation by electric shock
is the only known effective therapy of sudden cardiac death.
However, defibrillation has a significant side effect,
associated with electric field induced rupture of sarcolemmal
membrane known as electroporation. Electroporation is believed
to be responsible for clinical post-shock depression of
cardiac electrical and mechanical dysfunction, metabolic
inhibition, bradicardia, complete heart block and increased
pacing thresholds. Despite evident importance of
electroporation, little is known about spatiotemporal
mechanisms of development of electroporation and its
consequences in complex three-dimensional tissue structure of
the heart. The most striking puzzle is the existence of
experimental evidence for both pro- and anti-arrhythmic
effects of electroporation. The overall objective of the
project is to investigate the role of electroporation in
defibrillation.
Research of laboratory members
- Vadim Fedorov, PhD: Cardiac protection in hibernation, mechanisms of impulse generation
and conduction in the SA node, mechanisms of low-voltage defibrillation in the atria, mechanisms of VT/VF low
voltage termination in canine 4-day infarction model, mechanisms of electroporation and arrhythmia in the heart, optical imaging of the human heart;
- Christina Ambrosi: Optical coherence tomography and optical imaging of the human heart, imaging of the AV junction of the human heart, transcriptional regulation of gene expression in the human AV junction;
- Qing Luo: Panoramic imaging of cardiac defibrillation, effect of blebbistatin on genesis and maintenance of ventricular arrhythmia, calcium imaging of ventricular arrhythmia;
- Wenwen Li: Low-voltage termination of reentrant
arrhythmias in hearts with infarction and heart failure;
- Kelley Foyil: Low voltage atrial defibrllation, optical imaging of atrial arrhythmia, regional heterogeneity of gene expression in the atria.
- Alexey Glukhov, PhD, Mechanisms of electroporation, optical imaging of the mouse heart, mechanisms of impulse geenration in the mouse SA node.
Washington University Research Integrity Policy [html]
Washington University's Policy for Authorship on
Scientific and Scholarly Publications [html]
Selected publications
Mechanisms of arrhythmogenesis in the heart
- Flourescent imaging of stimulus-induced arrhythmogenesis [reprint]
- Computer simulations of cardiac excitation and arrhythmias [reprint]
- Topology of 3D scroll-waves induced by electric stimulation in the heart [reprint]
- Dynamics of scroll-waves in the heart during ventricular
tachycardia
- 3D fluorescent imaging of the AV nodal reentrant tachycardia [slides] [reprint]
Basic mechanisms of electric stimulation / defibrillation of the heart
- Mapping of cardiac stimulation [reprint]
- Epicardial Stimulation [reprint]
- Internal Defibrillation [reprint]
- Mechanisms of upper limit of vulnerability and defibrillation [reprint]
- External Defibrillation [reprint]
- Electroporation [reprint]
High-resolution fast fluorescent imaging
of electrical activity in heart
- Optical mapping of the AV node [reprint]
- Effects of voltage-sensitive dyes on cardiac cells [reprint]
- Data acquisition and processing: development of multi-channel
data acquisition & analysis system [reprint]
- Application of voltage-sensitive dye recording techniques
to human heart
|
|
 |